These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30459647)

  • 1. BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response.
    Lieb K; Dreimüller N; Wagner S; Schlicht K; Falter T; Neyazi A; Müller-Engling L; Bleich S; Tadić A; Frieling H
    Front Psychiatry; 2018; 9():511. PubMed ID: 30459647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
    Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
    World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.
    Engelmann J; Wagner S; Wollschläger D; Kaaden S; Schlicht KF; Dreimüller N; Braus DF; Müller MB; Tüscher O; Frieling H; Tadić A; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):183-193. PubMed ID: 30929060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylations of brain-derived neurotrophic factor exon VI are associated with major depressive disorder and antidepressant-induced remission in females.
    Li L; Wang T; Chen S; Yue Y; Xu Z; Yuan Y
    J Affect Disord; 2021 Dec; 295():101-107. PubMed ID: 34418778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF exon IV promoter methylation and antidepressant action: a complex interplay.
    Pathak H; Borchert A; Garaali S; Burkert A; Frieling H
    Clin Epigenetics; 2022 Dec; 14(1):187. PubMed ID: 36572893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Brain-Derived Neurotrophic Factor Exon IX Promoter Methylation, Protein, and mRNA Levels in Patients with Major Depressive Disorder.
    Hsieh MT; Lin CC; Lee CT; Huang TL
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31027379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
    Tadić A; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Röschke J; van Calker D; Wachtlin D; Kronfeld K; Gorbauch T; Seibert-Grafe M; Lieb K;
    Trials; 2010 Feb; 11():21. PubMed ID: 20187947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
    Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
    BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF)-epigenetic regulation in unipolar and bipolar affective disorder.
    Carlberg L; Scheibelreiter J; Hassler MR; Schloegelhofer M; Schmoeger M; Ludwig B; Kasper S; Aschauer H; Egger G; Schosser A
    J Affect Disord; 2014 Oct; 168():399-406. PubMed ID: 25106037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF promoter methylation and genetic variation in late-life depression.
    Januar V; Ancelin ML; Ritchie K; Saffery R; Ryan J
    Transl Psychiatry; 2015 Aug; 5(8):e619. PubMed ID: 26285129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder.
    Park YM; Lee BH
    Psychiatry Investig; 2018 Aug; 15(8):818-823. PubMed ID: 29945425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Methylation Patterns in Exon IV of the Brain-Derived Neurotrophic Factor (BDNF) Gene in Nicotine Dependence and Changes in BDNF Plasma Levels During Smoking Cessation.
    Abdelkhalek K; Rhein M; Deest M; Buchholz V; Bleich S; Lichtinghagen R; Vyssoki B; Frieling H; Muschler M; Proskynitopoulos PJ; Glahn A
    Front Psychiatry; 2022; 13():897801. PubMed ID: 35836661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in the anterior corona radiata in major depression.
    Choi S; Han KM; Won E; Yoon BJ; Lee MS; Ham BJ
    J Affect Disord; 2015 Feb; 172():74-80. PubMed ID: 25451398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients.
    Gutierrez A; Corey-Bloom J; Thomas EA; Desplats P
    Front Mol Neurosci; 2019; 12():335. PubMed ID: 32038165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring.
    Kawahori K; Hashimoto K; Yuan X; Tsujimoto K; Hanzawa N; Hamaguchi M; Kase S; Fujita K; Tagawa K; Okazawa H; Nakajima Y; Shibusawa N; Yamada M; Ogawa Y
    Thyroid; 2018 Mar; 28(3):395-406. PubMed ID: 29415629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation of brain-derived the neurotrophic factor gene promoter as a potent diagnostic and prognostic biomarker for post-traumatic stress disorder.
    Guo JC; Yang YJ; Zheng XA; Jiang XL; Guo M; Wang XD; Gao YS; Fu LQ; Chen XS
    Int J Clin Exp Pathol; 2018; 11(10):5101-5109. PubMed ID: 31949588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of tryptophan hydroxylase-2 methylation to early-life stress and its impact on short-term antidepressant treatment response.
    Shen T; Li X; Chen L; Chen Z; Tan T; Hua T; Chen B; Yuan Y; Zhang Z; Kuney L; Xu Z
    J Affect Disord; 2020 Nov; 276():850-858. PubMed ID: 32738671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.